Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
, creative, and well-organized candidate with experience in stem cell and cancer biology, molecular biology, next-generation sequencing techniques, bioinformatics, proteomic analysis, and animal handling
-
, economic, structural, and geographic factors affecting populations and communities. Plays a central role at the Polis Center by managing multiple research initiatives. Develops work plans and timelines
-
Related experience or clinical laboratory experience Experience utilizing a wide variety of methods including DNA/RNA extraction, PCR and Sanger Sequencing SKILLS Required Proficient communication skills
-
values, and aligning with IUSM strategic initiatives. Key Responsibilities and Expectations Institutional Leadership The Associate Center Director will: · Serve as part of the Leadership Team for IUSM-NW
-
-Residence, Entrepreneurs-in-Residence, and support pathways for SBIR/STTR funding and IP disclosure. Aligns the Center's goals with the IU 2030 Strategic Plan, tracking key performance indicators such as
-
between individuals and within communities. Collaborates with Office of Fraternity and Sorority life to ensure alignment with established hazing prevention practices, programming, and trainings. Serves as a
-
achieve marketing goals. Verifies factual accuracy and cross-referencing details for consistency across multiple pieces of content. Conducts quality control reviews of print, digital, and web content
-
key role in keeping clinic operations organized from managing after-hours messaging to verifying health records. Schedules and cancels appointments across multiple specialties, ensuring accuracy and
-
scholarship. Responsibilities: · Advance the IU Indianapolis 2030 strategic plan goals for CER by fostering a campus-wide culture that integrates community-engaged research and public scholarship, in alignment
-
, comprised of patients with advanced cancers who have had next-generation sequencing performed and from well-annotated clinical trials. This position is supported in part by the generous philanthropy from F3+R